Comparison of postoperative radiotherapy and combined postoperative radiotherapy and chemotherapy in the multidisciplinary management of malignant gliomas. A joint Radiation Therapy Oncology Group and Eastern Cooperative Oncology Group study.
about
Selective in vitro replication of herpes simplex virus type 1 (HSV-1) ICP34.5 null mutants in primary human CNS tumours--evaluation of a potentially effective clinical therapyIntraoperative radiation therapy (IORT) for previously untreated malignant gliomasTherapeutic interactions of autophagy with radiation and temozolomide in glioblastoma: evidence and issues to resolveCombined intra-arterial chemotherapy and irradiation of malignant gliomasThe future role of personalized medicine in the treatment of glioblastoma multiformeInterstitial chemotherapy with biodegradable BCNU (Gliadel) wafers in the treatment of malignant gliomas.Stereotactic radiosurgery versus fractionated stereotactic radiotherapy boost for patients with glioblastoma multiforme.Fractionated stereotactic radiotherapy boost and weekly paclitaxel in malignant gliomas clinical and pharmacokinetics results.Survival with dacarbazine and fotemustine in newly diagnosed glioblastoma multiforme.Temozolomide in combination with BCNU before and after radiotherapy in patients with inoperable newly diagnosed glioblastoma multiforme.Short delay in initiation of radiotherapy may not affect outcome of patients with glioblastoma: a secondary analysis from the radiation therapy oncology group database.The influence of the extent of surgery on the neurological function and survival in malignant glioma. A retrospective analysis in 243 patientsEffectiveness of temozolomide for primary glioblastoma multiforme in routine clinical practice.Oligodendroglioma: an analysis of 42 cases.Validation and simplification of the Radiation Therapy Oncology Group recursive partitioning analysis classification for glioblastomaChemotherapy for high-grade gliomas.Temozolomide: The evidence for its therapeutic efficacy in malignant astrocytomas.New methods for direct delivery of chemotherapy for treating brain tumors.Immunocytochemical studies on the effect of 405-nm low-power laser irradiation on human-derived A-172 glioblastoma cells.Brain tumors in the older person.Chemotherapy for high-grade glioma.Postoperative radiotherapy of astrocytomas.The prognosis of anaplastic astrocytoma with radiologic necrosis mimicking glioblastoma.Early toxicity predicts long-term survival in high-grade glioma.Grand rounds at the National Institutes of Health: HDAC inhibitors as radiation modifiers, from bench to clinicCarbamoylating chemoresistance induced by cobalt pretreatment in C6 glioma cells: putative roles of hypoxia-inducible factor-1.Phase II trial of radiosurgery to magnetic resonance spectroscopy-defined high-risk tumor volumes in patients with glioblastoma multiforme.Primary brain tumors in the older patient: an annotated review.Secondary gliosarcoma after the treatment of primary glioblastoma multiforme.Phase 2 trial of BCNU plus irinotecan in adults with malignant glioma.Phase 1 trial of irinotecan plus BCNU in patients with progressive or recurrent malignant glioma.Canadian recommendations for the treatment of glioblastoma multiforme.Standard fractionation intensity modulated radiation therapy (IMRT) of primary and recurrent glioblastoma multiformeA Medical Research Council trial of two radiotherapy doses in the treatment of grades 3 and 4 astrocytoma. The Medical Research Council Brain Tumour Working Party.Improving the acceptability of high-dose radiotherapy by reducing the duration of treatment: accelerated radiotherapy in high-grade glioma.Proliferation, migration and invasion of human glioma cells exposed to paclitaxel (Taxol) in vitro.Back to the future--radiotherapy in high grade gliomasAdvances in the management of glioblastoma: the role of temozolomide and MGMT testing.Malignant cerebral glioma--I: Survival, disability, and morbidity after radiotherapy.[Gliosarcoma: rare tumor of the central nervous system--presentation of two cases].
P2860
Q24679781-2BBC0837-C7C4-48EC-814B-7276689859D7Q24800235-54BB868E-986B-4A26-B158-A309AEF5DBC3Q26764947-E3268197-DD44-4B9D-A331-CF57372A4776Q28322050-15F46C0B-7178-4972-988E-EBF13AAECA16Q28391635-0156443B-639A-4FF4-8541-ED6D4393B568Q30441811-065CB607-F438-4787-B49B-FFBAE291C697Q33197247-DCCD691D-3A66-4B2D-A87C-66C99C586EAEQ33286061-258E75BA-5630-4D74-A649-FBAA282BFFC7Q33346613-5F4B58DE-A88B-4645-8B92-ED924D0388FBQ33366011-C1EDCF3F-1A22-41B3-99AD-71DA0D901C9AQ33396435-65F64E8B-4CB0-4C7E-B398-E9BC38CF584FQ33588924-4AE1922B-82F1-40E7-98FC-50A902709B6EQ33599200-9B02A875-4D1B-48B5-ABB9-4A128F5B3E3AQ33627931-3B09EE83-D66F-4443-8F9C-B3E39EF9AA50Q33708309-0E2FECD4-8DCE-47B5-ADB1-1EEB8764C94FQ33898570-8189A7F3-AF61-4C69-A33D-2ECD11CCB878Q33973844-75470A78-1ADB-440A-94A9-1D0ADA8D94A4Q34007625-EF52820C-6165-4337-ADC3-0BFA61889529Q34063254-30F9A96E-FF8C-47F1-A780-9CCE33BCD8A7Q34087862-8E30EDA0-5957-4B8C-8F32-5B93CF654EA5Q34169384-456401AE-6EAB-46E6-8CB9-E88A44D0683CQ34210447-708EF84B-AEC9-413D-A1D4-6B1155C48E8CQ34349906-A879966E-608A-43C2-BAF0-45DF50157843Q35006910-2E6F4A58-2E76-4F32-8BAB-8CF96B6E0C60Q35038016-62355D04-4082-4A58-BCBC-ADD3A4285011Q35046229-D8172C3E-5070-4C66-AA4F-9BC8C1684F7FQ35100924-1FDC583D-1E65-414B-BE13-6BF393D529A9Q35536315-27CBF00B-6312-473A-94AF-4C91DF4C291EQ35731710-C9D820F4-39D8-4E01-9D3F-F64CD630B4C4Q35800735-F59FD4F0-B45E-48AB-A3C1-26D8506EED62Q35800752-38253DD6-F4D8-4649-B8E1-EC163F137C1EQ35855352-20975CD6-104C-4313-A5D9-CA6E158A19A4Q35924621-2134C96E-0FA3-4BA5-8DFA-6AD3DAA6684AQ35993865-F8F37C9C-E847-4DE5-9F4C-B2FFD044F165Q36081097-BC6C6757-9E2D-422C-9EF6-9D5F1CE140D7Q36421995-EFBEF1D1-4C0E-4F77-9B1A-D48BDC57860EQ36468064-231FC5AE-600C-4CFC-9B45-19385AFA079AQ36500074-8B0AF909-F36B-4DDC-AC9D-070A55D91884Q36601793-5A89AF89-F2E9-4D06-883F-051CAB03C4F5Q36624285-D99A5A76-B09E-4EDB-BC8B-3276D78EF907
P2860
Comparison of postoperative radiotherapy and combined postoperative radiotherapy and chemotherapy in the multidisciplinary management of malignant gliomas. A joint Radiation Therapy Oncology Group and Eastern Cooperative Oncology Group study.
description
1983 nî lūn-bûn
@nan
1983 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1983 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1983年の論文
@ja
1983年論文
@yue
1983年論文
@zh-hant
1983年論文
@zh-hk
1983年論文
@zh-mo
1983年論文
@zh-tw
1983年论文
@wuu
name
Comparison of postoperative ra ...... perative Oncology Group study.
@ast
Comparison of postoperative ra ...... perative Oncology Group study.
@en
type
label
Comparison of postoperative ra ...... perative Oncology Group study.
@ast
Comparison of postoperative ra ...... perative Oncology Group study.
@en
prefLabel
Comparison of postoperative ra ...... perative Oncology Group study.
@ast
Comparison of postoperative ra ...... perative Oncology Group study.
@en
P2093
P2860
P1433
P1476
Comparison of postoperative ra ...... perative Oncology Group study.
@en
P2093
Perez-Tamayo R
Schoenfeld D
Weinstein A
P2860
P304
P356
10.1002/1097-0142(19830915)52:6<997::AID-CNCR2820520612>3.0.CO;2-2
P407
P577
1983-09-01T00:00:00Z